Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -70.36%-87.06K | 85.17%-93.48K | 70.28%-413K | 106.89%22.25K | 199.40%246.31K | 91.07%-51.1K | -155.45%-630.45K | 53.19%-1.39M | -322.68K | 89.81%-247.78K |
| Net income from continuing operations | 82.70%-678.33K | 82.14%-280.69K | -27.70%-7.15M | 112.79%534.54K | -390.01%-2.19M | -250.83%-3.92M | -48.20%-1.57M | 3.60%-5.6M | ---4.18M | 106.61%756.62K |
| Operating gains losses | -86.10%524.51K | -84.35%140.76K | 203.11%6.26M | -124.67%-847.77K | 303.78%2.43M | 2,470.56%3.77M | 4,958.15%899.68K | 2,844.60%2.06M | --3.44M | ---1.19M |
| Depreciation and amortization | --0 | --0 | -96.26%15.35K | --0 | --0 | --0 | -56.72%15.35K | 140.88%410.85K | --68.71K | 23.25%69.43K |
| Remuneration paid in stock | -75.44%11.15K | -76.80%17.5K | -78.79%181.96K | -60.38%28.55K | -34.32%32.56K | -83.49%45.42K | -83.65%75.43K | -46.37%858.03K | --72.07K | -80.57%49.58K |
| Other non cashItems | ---- | ---- | -67.09%71.78K | -99.97%16 | --0 | -100.03%-16 | 32.52%71.78K | 203.75%218.13K | --53.08K | -61.86%54.65K |
| Change In working capital | 10.91%55.61K | 123.85%28.95K | -68.04%210.5K | 35.88%306.92K | -257.82%-25.18K | -63.06%50.14K | -143.19%-121.39K | -51.42%658.63K | --225.88K | 101.72%15.95K |
| -Change in receivables | 75.30%-1.43K | -68.00%368 | -99.29%2.17K | -85.16%10.39K | 83.95%-3.58K | 86.69%-5.8K | -99.62%1.15K | -13.01%305.07K | --70.01K | 97.96%-22.29K |
| -Change in prepaid assets | -6.70%18.5K | 82.40%-30.55K | -66.89%-54.78K | --87.37K | --11.62K | 88.65%19.83K | -1,551.67%-173.59K | -109.08%-32.82K | ---- | ---- |
| -Change in payables and accrued expense | -247.00%-46.55K | 15.82%59.13K | -63.81%57.08K | -70.08%30.31K | -46.76%-55.95K | -72.31%31.67K | 357.31%51.06K | -75.50%157.71K | --101.31K | -105.81%-38.12K |
| -Change in other working capital | ---- | ---- | -9.90%206.03K | 104.69%178.85K | -70.24%22.73K | ---- | ---- | --228.67K | --87.38K | --76.36K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -70.36%-87.06K | 85.17%-93.48K | 70.28%-413K | 106.89%22.25K | 199.40%246.31K | 91.07%-51.1K | -155.45%-630.45K | 53.19%-1.39M | ---322.68K | 89.81%-247.78K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 106.20%4.76K | 92.95%-9.34K | 68.47%-297.82K | -127.43%-76.17K | 98.63%-12.46K | 58.35%-76.77K | -4.93%-132.41K | 66.52%-944.65K | 277.71K | -202.60%-911.83K |
| Net PPE purchase and sale | --0 | --0 | 96.62%-11.92K | --0 | --0 | --0 | 90.56%-11.92K | 96.25%-352.04K | --94.07K | -157.29%-135.58K |
| Net business purchase and sale | ---- | ---- | 97.64%-18.34K | --0 | --0 | ---- | ---- | -111.82%-776.25K | --0 | ---776.25K |
| Net investment purchase and sale | 108.14%4.76K | 92.25%-9.34K | -204.87%-192.57K | ---1.17K | ---12.46K | ---58.44K | ---120.5K | 419.36%183.63K | ---- | ---- |
| Interest received (cash flow from investment activities) | ---- | ---- | ---75K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 106.20%4.76K | 92.95%-9.34K | 68.47%-297.82K | -127.43%-76.17K | 98.63%-12.46K | 58.35%-76.77K | -4.93%-132.41K | 66.52%-944.65K | --277.71K | -202.60%-911.83K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | -91.95%216.61K | -102.13%-15.74K | 0 | -99.91%1.25K | -37.61%231.1K | -56.32%2.69M | 740.06K | 169.24K |
| Net issuance payments of debt | --0 | --0 | 32.31%-344.24K | --0 | --0 | --0 | -1.25%-344.24K | -113.55%-508.57K | --0 | --0 |
| Net common stock issuance | --0 | --0 | -77.48%558.35K | -102.13%-15.74K | --0 | --0 | -19.18%574.09K | 2.92%2.48M | --740.06K | --169.24K |
| Proceeds from stock option exercised by employees | --0 | --0 | --2.5K | --0 | --0 | --1.25K | --1.25K | --0 | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --720.71K | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | -91.95%216.61K | -102.13%-15.74K | --0 | -99.91%1.25K | -37.61%231.1K | -56.32%2.69M | --740.06K | --169.24K |
| Net cash flow | ||||||||||
| Beginning cash position | -29.76%119.91K | -69.16%224.48K | 96.17%727.84K | 798.95%294.15K | -95.72%43.78K | -53.76%170.71K | 96.17%727.84K | --371.02K | --32.72K | -72.57%1.02M |
| Current changes in cash | 35.01%-82.3K | 80.67%-102.82K | -238.51%-494.21K | -110.02%-69.67K | 123.61%233.85K | -119.34%-126.62K | -20,336.66%-531.76K | -3.83%356.81K | --695.08K | 35.82%-990.38K |
| Effect of exchange rate changes | 105.47%17 | -151.84%-1.75K | 150,623.08%19.59K | -97.56%1 | 59,121.43%16.53K | 61.41%-311 | 319.11%3.38K | 208.33%13 | --41 | ---28 |
| Cash adjustments other than cash changes | --0 | --0 | ---28.75K | --0 | --0 | --0 | ---28.75K | --0 | ---- | ---- |
| End cash Position | -14.03%37.63K | -29.76%119.91K | -69.16%224.48K | -69.16%224.48K | 798.95%294.15K | -95.72%43.78K | -53.76%170.71K | 96.17%727.84K | --727.84K | -98.50%32.72K |
| Free cash from | -70.36%-87.06K | 85.45%-93.48K | 81.10%-424.92K | 109.73%22.25K | 164.25%246.31K | 95.96%-51.1K | -72.22%-642.37K | 82.20%-2.25M | ---228.61K | 75.16%-383.36K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.